Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review
- Authors: Sani G.1, Callovini T.2, Ferrara O.3, Segatori D.4, Margoni S.4, Simonetti A.5, Lisci F.4, Marano G.5, Fischetti A.4, Kotzalidis G.5, Di Segni F.6, Fiaschè F.7, Janiri D.5, Moccia L.8, Manfredi G.9, Alcibiade A.6, Brisi C.4, Grisoni F.4, Stella G.3, Bernardi E.3, Brugnami A.3, Ciliberto M.4, Spera M.10, Caso R.10, Rossi S.3, Boggio G.4, Mastroeni G.3, Abate F.4, Conte E.10, Quintano A.4, De Chiara L.11, Monti L.12, Camardese G.8, Rinaldi L.1, Koukopoulos A.13, Chieffo D.12, Angeletti G.14, Mazza M.8
-
Affiliations:
- Department of Psychiatry,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS,
- Department of Medicine and Surgery,, University of Milano-Bicocca
- Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore
- Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
- Department of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Psychiatry Residency Training Programme, Faculty of Medicine and Psychology, Sapienza University of Rome
- ASL RM1, Presidio Ospedaliero San Filippo Neri, Servizio Psichiatrico di Diagnosi e Cura
- Department of Psychiatry,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- UOC Psichiatria, Day Hospital, Sant'Andrea Teaching Hospital, Sapienza University of Rome
- Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore,
- , Struttura Residenziale Psichiatrica Samadi S.p.A.
- UOS Clinical Psychology, Clinical Government, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Azienda Ospedaliera Universitaria Policlinico Umberto I, Viale dellUniversità 30
- Sapienza University of Rome, Sant'Andrea Hospital, Sapienza University of Rome
- Issue: Vol 22, No 14 (2024)
- Pages: 2402-2421
- Section: Neurology
- URL: https://ruspoj.com/1570-159X/article/view/644570
- DOI: https://doi.org/10.2174/1570159X22666240516151449
- ID: 644570
Cite item
Full Text
Abstract
:There is much debate about continuing antipsychotic medication in patients who need it when they become pregnant because benefits must be weighed against potential teratogenic and malformation effects related to antipsychotics themselves. To address this, we conducted a systematic review on the PubMed, PsycINFO and CINHAL databases and the ClinicalTrials.gov register using the following strategy: (toxicity OR teratogenicity OR malformation* OR \"birth defect*\" OR \"congenital abnormality\" OR \"congenital abnormalities\" OR \"brain changes\" OR \"behavioral abnormalities\" OR \"behavioral abnormalities\") AND antipsychotic* AND (pregnancy OR pregnant OR lactation OR delivery OR prenatal OR perinatal OR post-natal OR puerperium) on September 27, 2023. We found 38 studies to be eligible. The oldest was published in 1976, while most articles were recent. Most studies concluded that the antipsychotics, especially the second-generation antipsychotics, were devoid of teratogenic potential, while few studies were inconclusive and recommended replication. Most authoritative articles were from the Boston area, where large databases were implemented to study the malformation potential of psychiatric drugs. Other reliable databases are from Northern European registers. Overall conclusions are that antipsychotics are no more related to malformations than the disorders themselves; most studies recommend that there are no reasons to discontinue antipsychotic medications in pregnancy
About the authors
Gabriele Sani
Department of Psychiatry,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS,
Email: info@benthamscience.net
Tommaso Callovini
Department of Medicine and Surgery,, University of Milano-Bicocca
Email: info@benthamscience.net
Ottavia Ferrara
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Daniele Segatori
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Stella Margoni
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Alessio Simonetti
Department of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email: info@benthamscience.net
Francesco Lisci
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Giuseppe Marano
Department of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email: info@benthamscience.net
Alessia Fischetti
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Georgios Kotzalidis
Department of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Author for correspondence.
Email: info@benthamscience.net
Federica Di Segni
Psychiatry Residency Training Programme, Faculty of Medicine and Psychology, Sapienza University of Rome
Email: info@benthamscience.net
Federica Fiaschè
ASL RM1, Presidio Ospedaliero San Filippo Neri, Servizio Psichiatrico di Diagnosi e Cura
Email: info@benthamscience.net
Delfina Janiri
Department of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email: info@benthamscience.net
Lorenzo Moccia
Department of Psychiatry,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email: info@benthamscience.net
Giovanni Manfredi
UOC Psichiatria, Day Hospital, Sant'Andrea Teaching Hospital, Sapienza University of Rome
Email: info@benthamscience.net
Alessandro Alcibiade
Psychiatry Residency Training Programme, Faculty of Medicine and Psychology, Sapienza University of Rome
Email: info@benthamscience.net
Caterina Brisi
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Flavia Grisoni
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Gianmarco Stella
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Evelina Bernardi
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Andrea Brugnami
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Michele Ciliberto
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Maria Spera
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore,
Email: info@benthamscience.net
Romina Caso
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore,
Email: info@benthamscience.net
Sara Rossi
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Gianluca Boggio
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Giulia Mastroeni
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Francesca Abate
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Eliana Conte
Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore,
Email: info@benthamscience.net
Anna Quintano
Department of Neuroscience, Section of Psychiatry,, Università Cattolica del Sacro Cuore
Email: info@benthamscience.net
Lavinia De Chiara
, Struttura Residenziale Psichiatrica Samadi S.p.A.
Email: info@benthamscience.net
Laura Monti
UOS Clinical Psychology, Clinical Government, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email: info@benthamscience.net
Giovanni Camardese
Department of Psychiatry,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email: info@benthamscience.net
Lucio Rinaldi
Department of Psychiatry,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS,
Email: info@benthamscience.net
Alexia Koukopoulos
Azienda Ospedaliera Universitaria Policlinico Umberto I, Viale dellUniversità 30
Email: info@benthamscience.net
Daniela Chieffo
UOS Clinical Psychology, Clinical Government, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email: info@benthamscience.net
Gloria Angeletti
Sapienza University of Rome, Sant'Andrea Hospital, Sapienza University of Rome
Email: info@benthamscience.net
Marianna Mazza
Department of Psychiatry,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email: info@benthamscience.net
References
- Davies, C.; Segre, G.; Estradé, A.; Radua, J.; De Micheli, A.; Provenzani, U.; Oliver, D.; Salazar de Pablo, G.; Ramella-Cravaro, V.; Besozzi, M.; Dazzan, P.; Miele, M.; Caputo, G.; Spallarossa, C.; Crossland, G.; Ilyas, A.; Spada, G.; Politi, P.; Murray, R.M.; McGuire, P.; Fusar-Poli, P. Prenatal and perinatal risk and protective factors for psychosis: A systematic review and meta-analysis. Lancet Psychiatry, 2020, 7(5), 399-410. doi: 10.1016/S2215-0366(20)30057-2 PMID: 32220288
- Howard, L.M.; Khalifeh, H. Perinatal mental health: A review of progress and challenges. World Psychiatry, 2020, 19(3), 313-327. doi: 10.1002/wps.20769 PMID: 32931106
- Orsolini, L.; Sceusa, F.; Pompili, S.; Mauro, A.; Salvi, V.; Volpe, U. Severe and persistent mental illness (SPMI) in pregnancy and breastfeeding: Focus on second-generation long acting injectable antipsychotics. Expert Opin. Drug Saf., 2021, 20(10), 1207-1224. doi: 10.1080/14740338.2021.1928634 PMID: 33966552
- Wesseloo, R.; Kamperman, A.M.; Bergink, V.; Pop, V.J.M. Thyroid peroxidase antibodies during early gestation and the subsequent risk of first-onset postpartum depression: A prospective cohort study. J. Affect. Disord., 2018, 225, 399-403. doi: 10.1016/j.jad.2017.08.058 PMID: 28850854
- Valdimarsdóttir, U.; Hultman, C.M.; Harlow, B.; Cnattingius, S.; Sparén, P. Psychotic illness in first-time mothers with no previous psychiatric hospitalizations: A population-based study. PLoS Med., 2009, 6(2), e1000013. doi: 10.1371/journal.pmed.1000013 PMID: 19209952
- OHara, M.W.; Wisner, K.L. Perinatal mental illness: Definition, description and aetiology. Best Pract. Res. Clin. Obstet. Gynaecol., 2014, 28(1), 3-12. doi: 10.1016/j.bpobgyn.2013.09.002 PMID: 24140480
- Cuomo, A.; Goracci, A.; Fagiolini, A. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. J. Affect. Disord., 2018, 228, 229-237. doi: 10.1016/j.jad.2017.12.021 PMID: 29275156
- Winans, E.A. Antipsychotics and Breastfeeding. J. Hum. Lact., 2001, 17(4), 344-347. doi: 10.1177/089033440101700408 PMID: 11847903
- Conejo-Galindo, J.; Sanz-Giancola, A.; Álvarez-Mon, M.Á.; Ortega, M.Á.; Gutiérrez-Rojas, L.; Lahera, G. Postpartum relapse in patients with bipolar disorder. J. Clin. Med., 2022, 11(14), 3979. doi: 10.3390/jcm11143979 PMID: 35887743
- Edinoff, A.N.; Sathivadivel, N.; McNeil, S.E.; Ly, A.I.; Kweon, J.; Kelkar, N.; Cornett, E.M.; Kaye, A.M.; Kaye, A.D. Antipsychotic use in pregnancy: Patient mental health challenges, teratogenicity, pregnancy complications, and postnatal risks. Neurol. Int., 2022, 14(1), 62-74. doi: 10.3390/neurolint14010005 PMID: 35076595
- Munk-Olsen, T.; Laursen, T.M.; Mendelson, T.; Pedersen, C.B.; Mors, O.; Mortensen, P.B. Risks and predictors of readmission for a mental disorder during the postpartum period. Arch. Gen. Psychiatry, 2009, 66(2), 189-195. doi: 10.1001/archgenpsychiatry.2008.528 PMID: 19188541
- Sprague, J.; Wisner, K.L.; Bogen, D.L. Pharmacotherapy for depression and bipolar disorder during lactation: A framework to aid decision making. Semin. Perinatol., 2020, 44(3), 151224. doi: 10.1016/j.semperi.2020.151224 PMID: 32199600
- McAllister-Williams, R.H.; Baldwin, D.S.; Cantwell, R.; Easter, A.; Gilvarry, E.; Glover, V.; Green, L.; Gregoire, A.; Howard, L.M.; Jones, I.; Khalifeh, H.; Lingford-Hughes, A.; McDonald, E.; Micali, N.; Pariante, C.M.; Peters, L.; Roberts, A.; Smith, N.C.; Taylor, D.; Wieck, A.; Yates, L.M.; Young, A.H. British association for psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J. Psychopharmacol., 2017, 31(5), 519-552. doi: 10.1177/0269881117699361 PMID: 28440103
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; Chou, R.; Glanville, J.; Grimshaw, J.M.; Hróbjartsson, A.; Lalu, M.M.; Li, T.; Loder, E.W.; Mayo-Wilson, E.; McDonald, S.; McGuinness, L.A.; Stewart, L.A.; Thomas, J.; Tricco, A.C.; Welch, V.A.; Whiting, P.; Moher, D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021, 372(71), n71. doi: 10.1136/bmj.n71 PMID: 33782057
- ROBINS-E Development Group. Higgins, J.; Morgan, R.; Rooney, A.; Taylor, K.; Thayer, K.; Silva, R .; Lemeris, C.; Akl, A.; Arroyave, W.; Bateson, T.; Berkman, N.; Demers, P.; Forastiere, F.; Glenn, B.; Hróbjartsson, A.; Kirrane, E.; LaKind, J.; Luben, T.; Lunn, R.; McAleenan, A.; McGuinness, L.; Meerpohl, J.; Mehta, S.; Nachman, R.; Obbagy, J.; O'Connor, A.; Radke, E.; Savović, J.; Schubauer-Berigan, M.; Schwingl, P.; Schunemann, H.; Shea, B.; Steenland, K.; Stewart, T.; Straif, K.; Tilling, K.; Verbeek, V.; Vermeulen, R.; Viswanathan, M.; Zahm, S.; Sterne, J. Risk Of Bias In Non-randomized Studies of Exposure (ROBINS-E). Launch version, 20 June 2023. Available from: https://www.riskofbias.info/welcome/robins-e-tool (assessed on August 25, 2023.)
- Rieder, R.O.; Rosenthal, D.; Wender, P.; Blumenthal, H. The offspring of schizophrenics. Fetal and neonatal deaths. Arch. Gen. Psychiatry, 1975, 32(2), 200-211. doi: 10.1001/archpsyc.1975.01760200064006 PMID: 234727
- Milkovich, L.; van den Berg, B.J. An evaluation of the teratogenicity of certain antinauseant drugs. Am. J. Obstet. Gynecol., 1976, 125(2), 244-248. doi: 10.1016/0002-9378(76)90601-3 PMID: 773181
- McKeigue, P.M.; Lamm, S.H.; Linn, S.; Kutcher, J.S. Bendectin and birth defects: I. A meta‐analysis of the epidemiologic studies. Teratology, 1994, 50(1), 27-37. doi: 10.1002/tera.1420500105 PMID: 7974252
- Slone, D.; Siskind, V.; Heinonen, O.P.; Monson, R.R.; Kaufman, D.W.; Shapiro, S. Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am. J. Obstet. Gynecol., 1977, 128(5), 486-488. doi: 10.1016/0002-9378(77)90029-1 PMID: 879206
- Godet, P.F.; Marie-Cardine, M. Neuroleptiques, schizophrénie et grossesse. Etude épidémiologique et tératologique. Encephale, 1991, 17(6), 543-547. PMID: 1687216
- Sharma, J.B.; Sharma, S. Role of thioridazine in unexplained infertility. Int. J. Gynaecol. Obstet., 1992, 37(1), 37-41. doi: 10.1016/0020-7292(92)90975-O PMID: 1346599
- Goldstein, D.J.; Corbin, L.A.; Fung, M.C. Olanzapine-exposed pregnancies and lactation: Early experience. J. Clin. Psychopharmacol., 2000, 20(4), 399-403. doi: 10.1097/00004714-200008000-00002 PMID: 10917399
- Diav-Citrin, O.; Shechtman, S.; Ornoy, S.; Arnon, J.; Schaefer, C.; Garbis, H.; Clementi, M.; Ornoy, A. Safety of haloperidol and penfluridol in pregnancy: A multicenter, prospective, controlled study. J. Clin. Psychiatry, 2005, 66(3), 317-322. doi: 10.4088/JCP.v66n0307 PMID: 15766297
- McKenna, K.; Koren, G.; Tetelbaum, M.; Wilton, L.; Shakir, S.; Diav-Citrin, O.; Levinson, A.; Zipursky, R.B.; Einarson, A. Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study. J. Clin. Psychiatry, 2005, 66(4), 444-449. doi: 10.4088/JCP.v66n0406 PMID: 15816786
- Reis, M.; Källén, B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J. Clin. Psychopharmacol., 2008, 28(3), 279-288. doi: 10.1097/JCP.0b013e318172b8d5 PMID: 18480684
- Babu, G.N.; Desai, G.; Tippeswamy, H.; Chandra, P.S. Birth weight and use of olanzapine in pregnancy: A prospective comparative study. J. Clin. Psychopharmacol., 2010, 30(3), 331-332. doi: 10.1097/JCP.0b013e3181db8734 PMID: 20473073
- Gilad, O.; Merlob, P.; Stahl, B.; Klinger, G. Outcome of infants exposed to olanzapine during breastfeeding. Breastfeed. Med., 2011, 6(2), 55-58. doi: 10.1089/bfm.2010.0027 PMID: 21034242
- Habermann, F.; Fritzsche, J.; Fuhlbrück, F.; Wacker, E.; Allignol, A.; Weber-Schoendorfer, C.; Meister, R.; Schaefer, C. Atypical antipsychotic drugs and pregnancy outcome: A prospective, cohort study. J. Clin. Psychopharmacol., 2013, 33(4), 453-462. doi: 10.1097/JCP.0b013e318295fe12 PMID: 23764684
- Sadowski, A.; Todorow, M.; Yazdani Brojeni, P.; Koren, G.; Nulman, I. Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: A cohort study. BMJ Open, 2013, 3(7), e003062. doi: 10.1136/bmjopen-2013-003062 PMID: 23852139
- Bellet, F.; Beyens, M.N.; Bernard, N.; Beghin, D.; Elefant, E.; Vial, T. Exposure to aripiprazole during embryogenesis: A prospective multicenter cohort study. Pharmacoepidemiol. Drug Saf., 2015, 24(4), 368-380. doi: 10.1002/pds.3749 PMID: 25683615
- Cohen, L.S.; Viguera, A.C.; McInerney, K.A.; Freeman, M.P.; Sosinsky, A.Z.; Moustafa, D.; Marfurt, S.P.; Kwiatkowski, M.A.; Murphy, S.K.; Farrell, A.M.; Chitayat, D.; Hernández-Díaz, S. Reproductive safety of second-generation antipsychotics: Current data from the massachusetts general hospital national pregnancy registry for atypical antipsychotics. Am. J. Psychiatry, 2016, 173(3), 263-270. doi: 10.1176/appi.ajp.2015.15040506 PMID: 26441156
- Montastruc, F.; Salvo, F.; Arnaud, M.; Bégaud, B.; Pariente, A. Signal of gastrointestinal congenital malformations with antipsychotics after minimising competition bias: A disproportionality analysis using data from Vigibase. Drug Saf., 2016, 39(7), 689-696. doi: 10.1007/s40264-016-0413-1 PMID: 26961536
- Petersen, I.; McCrea, R.L.; Sammon, C.J.; Osborn, D.P.J.; Evans, S.J.; Cowen, P.J.; Freemantle, N.; Nazareth, I. Risks and benefits of psychotropic medication in pregnancy: Cohort studies based on UK electronic primary care health records. Health Technol. Assess., 2016, 20(23), 1-176. doi: 10.3310/hta20230 PMID: 27029490
- Petersen, I.; Sammon, C.J.; McCrea, R.L.; Osborn, D.P.J.; Evans, S.J.; Cowen, P.J.; Nazareth, I. Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records. Schizophr. Res., 2016, 176(2-3), 349-356. doi: 10.1016/j.schres.2016.07.023 PMID: 27484686
- Huybrechts, K.F.; Hernández-Díaz, S.; Patorno, E.; Desai, R.J.; Mogun, H.; Dejene, S.Z.; Cohen, J.M.; Panchaud, A.; Cohen, L.; Bateman, B.T. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry, 2016, 73(9), 938-946. doi: 10.1001/jamapsychiatry.2016.1520 PMID: 27540849
- Hatters, F.S.; Moller-Olsen, C.; Prakash, C.; North, A. Atypical antipsychotic use and outcomes in an urban maternal mental health service. Int. J. Psychiatry Med., 2016, 51(6), 521-533. doi: 10.1177/0091217417696739 PMID: 28629296
- Shin, Y.J.; Choi, J.S.; Ahn, H.K.; Ryu, H.M.; Kim, M.Y.; Han, J.Y. Pregnancy outcomes in women reporting ingestion of levosulpiride in early pregnancy. J. Obstet. Gynaecol., 2017, 37(8), 992-995. doi: 10.1080/01443615.2017.1312307 PMID: 28631490
- Onken, M.; Mick, I.; Schaefer, C. Paliperidone and pregnancy: An evaluation of the German Embryotox database. Arch. Women Ment. Health, 2018, 21(6), 657-662. doi: 10.1007/s00737-018-0828-z PMID: 29569043
- Galbally, M.; Frayne, J.; Watson, S.J.; Snellen, M. Aripiprazole and pregnancy: A retrospective, multicentre study. J. Affect. Disord., 2018, 238, 593-596. doi: 10.1016/j.jad.2018.06.004 PMID: 29957476
- Cohen, L.S.; Góez-Mogollón, L.; Sosinsky, A.Z.; Savella, G.M.; Viguera, A.C.; Chitayat, D.; Hernández-Díaz, S.; Freeman, M.P. Risk of major malformations in infants following first-trimester exposure to quetiapine. Am. J. Psychiatry, 2018, 175(12), 1225-1231. doi: 10.1176/appi.ajp.2018.18010098 PMID: 30111186
- Anderson, K.N.; Ailes, E.C.; Lind, J.N.; Broussard, C.S.; Bitsko, R.H.; Friedman, J.M.; Bobo, W.V.; Reefhuis, J.; Tinker, S.C. Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 19972011. Schizophr. Res., 2020, 215, 81-88. doi: 10.1016/j.schres.2019.11.019 PMID: 31761471
- Ellfolk, M.; Leinonen, M.K.; Gissler, M.; Lahesmaa-Korpinen, A.M.; Saastamoinen, L.; Nurminen, M.L.; Malm, H. Second-generation antipsychotics and pregnancy complications. Eur. J. Clin. Pharmacol., 2020, 76(1), 107-115. doi: 10.1007/s00228-019-02769-z PMID: 31680189
- Ellfolk, M.; Leinonen, M.K.; Gissler, M.; Kiuru-Kuhlefelt, S.; Saastamoinen, L.; Malm, H. Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur. J. Clin. Pharmacol., 2021, 77(11), 1737-1745. doi: 10.1007/s00228-021-03169-y PMID: 34100993
- Freeman, M.P.; Viguera, A.C.; Góez-Mogollón, L.; Young, A.V.; Caplin, P.S.; McElheny, S.A.; Church, T.R.; Chitayat, D.; Hernández-Díaz, S.; Cohen, L.S. Reproductive safety of aripiprazole: Data from the massachusetts general hospital national pregnancy registry for atypical antipsychotics. Arch. Women Ment. Health, 2021, 24(4), 659-667. doi: 10.1007/s00737-021-01115-6 PMID: 33710399
- Viguera, A.C.; Freeman, M.P.; Góez-Mogollón, L.; Sosinsky, A.Z.; McElheny, S.A.; Church, T.R.; Young, A.V.; Caplin, P.S.; Chitayat, D.; Hernández-Díaz, S.; Cohen, L.S. Reproductive safety of second-generation antipsychotics: updated data from the massachusetts general hospital national pregnancy registry for atypical antipsychotics. J. Clin. Psychiatry, , 2021, 82(4), 20m13745. doi: 10.4088/JCP.20m13745
- Nguyen, T.; Frayne, J.; Watson, S.; Lebedevs, T.; Teoh, S.; Galbally, M. Long-acting injectable antipsychotic treatment during pregnancy: Outcomes for women at a tertiary maternity hospital. Psychiatry Res., 2022, 313, 114614. doi: 10.1016/j.psychres.2022.114614 PMID: 35576628
- Yakuwa, N.; Takahashi, K.; Anzai, T.; Ito, N.; Goto, M.; Koinuma, S.; Uno, C.; Suzuki, T.; Watanabe, O.; Yamatani, A.; Murashima, A. Pregnancy outcomes with exposure to second-generation antipsychotics during the first trimester. Clin. Psychiatry, 2022, 83(4), 21m14081. doi: 10.4088/JCP.21m14081
- Hálfdánarson, Ó.; Cohen, J.M.; Karlstad, Ø.; Cesta, C.E.; Bjørk, M.H.; Håberg, S.E.; Einarsdóttir, K.; Furu, K.; Gissler, M.; Hjellvik, V.; Kieler, H.; Leinonen, M.K.; Nørgaard, M.; Öztürk Esen, B.; Ulrichsen, S.P.; Reutfors, J.; Zoega, H. Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: A Nordic cohort study. Evid. Based Ment. Health, 2022, 25(2), 54-62. doi: 10.1136/ebmental-2021-300311 PMID: 34810174
- Straub, L.; Hernández-Díaz, S.; Bateman, B.T.; Wisner, K.L.; Gray, K.J.; Pennell, P.B.; Lester, B.; McDougle, C.J.; Suarez, E.A.; Zhu, Y.; Zakoul, H.; Mogun, H.; Huybrechts, K.F. Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: A National Birth Cohort Study. JAMA Intern. Med., 2022, 182(5), 522-533. doi: 10.1001/jamainternmed.2022.0375 PMID: 35343998
- Huybrechts, K.F.; Straub, L.; Karlsson, P.; Pazzagli, L.; Furu, K.; Gissler, M.; Hernandez-Diaz, S.; Nørgaard, M.; Zoega, H.; Bateman, B.T.; Cesta, C.E.; Cohen, J.M.; Leinonen, M.K.; Reutfors, J.; Selmer, R.M.; Suarez, E.A.; Ulrichsen, S.P.; Kieler, H. Association of in utero antipsychotic medication exposure with risk of congenital malformations in Nordic countries and the US. JAMA Psychiatry, 2023, 80(2), 156-166. doi: 10.1001/jamapsychiatry.2022.4109 PMID: 36477338
- Cohen, L.S.; Church, T.R.; Freeman, M.P.; Gaccione, P.; Caplin, P.S.; Kobylski, L.A.; Arakelian, M.; Rossa, E.T.; Chitayat, D.; Hernández-Díaz, S.; Viguera, A.C. Reproductive safety of lurasidone and quetiapine: Update from the national pregnancy registry for psychiatric medications. J. Womens Health , 2023, 32(4), 452-462. doi: 10.1089/jwh.2022.0310 PMID: 36716275
- Viguera, A.C.; Freeman, M.P.; Kobylski, L.A.; Rossa, E.T.; Gaccione, P.; Chitayat, D.; Hernández-Díaz, S.; Cohen, L.S. Risk of major malformations following first-trimester exposure to olanzapine: Preliminary data from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. J. Clin. Psychopharmacol., 2023, 43(2), 106-112. doi: 10.1097/JCP.0000000000001665 PMID: 36825887
- Liu, X.; Kolding, L.; Momen, N.; Gasse, C.; Pedersen, L.H. Maternal antipsychotic use during pregnancy and congenital malformations. Am. J. Obstet. Gynecol. MFM, 2023, 5(6), 100950. doi: 10.1016/j.ajogmf.2023.100950 PMID: 37015311
- Schrijver, L.; Robakis, T.K.; Kamperman, A.M.; Bijma, H.; Honig, A.; van Kamp, I.L.; Hoogendijk, W.J.G.; Bergink, V.; Poels, E.M.P. Neurodevelopment in school‐aged children after intrauterine exposure to antipsychotics. Acta Psychiatr. Scand., 2023, 147(1), 43-53. doi: 10.1111/acps.13517 PMID: 36333825
- Idänpään-Heikkilä, J.; Alhava, E.; Olkinuora, M.; Palva, I. Letter: Clozapine and agranulocytosis. Lancet, 1975, 306(7935), 611. doi: 10.1016/S0140-6736(75)90206-8 PMID: 51442
- Meltzer, H.Y.; Bastani, B.; Ramirez, L.; Matsubara, S. Clozapine: New research on efficacy and mechanism of action. Eur. Arch. Psychiatry Neurol. Sci., 1989, 238(5-6), 332-339. doi: 10.1007/BF00449814 PMID: 2569975
- Perrault, G.; Schoemaker, H.; Scatton, B. Place de lamisulpride dans la classe des neuroleptiques atypiques. Encephale, 1996, 22(Spec No 2), 3-8. PMID: 8767034
- Citrome, L.; Holt, R.I.G.; Walker, D.J.; Hoffmann, V.P. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder. Clin. Drug Investig., 2011, 31(7), 455-482. doi: 10.2165/11589060-000000000-00000 PMID: 21495734
- Lambert, T.J.R. Switching to aripiprazole from olanzapine leads to weight loss in overweight people with schizophrenia or schizoaffective disorder. Evid. Based Ment. Health, 2009, 12(2), 50. doi: 10.1136/ebmh.12.2.50 PMID: 19395609
- Tyrrell, J.; Richmond, R.C.; Palmer, T.M.; Feenstra, B.; Rangarajan, J.; Metrustry, S.; Cavadino, A.; Paternoster, L.; Armstrong, L.L.; De Silva, N.M.G.; Wood, A.R.; Horikoshi, M.; Geller, F.; Myhre, R.; Bradfield, J.P.; Kreiner-Møller, E.; Huikari, V.; Painter, J.N.; Hottenga, J.J.; Allard, C.; Berry, D.J.; Bouchard, L.; Das, S.; Evans, D.M.; Hakonarson, H.; Hayes, M.G.; Heikkinen, J.; Hofman, A.; Knight, B.; Lind, P.A.; McCarthy, M.I.; McMahon, G.; Medland, S.E.; Melbye, M.; Morris, A.P.; Nodzenski, M.; Reichetzeder, C.; Ring, S.M.; Sebert, S.; Sengpiel, V.; Sørensen, T.I.A.; Willemsen, G.; de Geus, E.J.C.; Martin, N.G.; Spector, T.D.; Power, C.; Järvelin, M.R.; Bisgaard, H.; Grant, S.F.A.; Nohr, E.A.; Jaddoe, V.W.; Jacobsson, B.; Murray, J.C.; Hocher, B.; Hattersley, A.T.; Scholtens, D.M.; Davey Smith, G.; Hivert, M.F.; Felix, J.F.; Hyppönen, E.; Lowe, W.L., Jr; Frayling, T.M.; Lawlor, D.A.; Freathy, R.M. Genetic evidence for causal relationships between maternal obesity-related traits and birth weight. JAMA, 2016, 315(11), 1129-1140. doi: 10.1001/jama.2016.1975 PMID: 26978208
- Schmidt, M.; Schmidt, S.A.J.; Sandegaard, J.L.; Ehrenstein, V.; Pedersen, L.; Sørensen, H.T. The danish national patient registry: A review of content, data quality, and research potential. Clin. Epidemiol., 2015, 7, 449-490. doi: 10.2147/CLEP.S91125 PMID: 26604824
- Lynge, E.; Sandegaard, J.L.; Rebolj, M. The danish national patient register. Scand. J. Public Health,, 2011, 39(7_suppl)(Suppl.), 30-33. doi: 10.1177/1403494811401482 PMID: 21775347
- Cohen, L.S.; Viguera, A.C.; McInerney, K.A.; Kwiatkowski, M.A.; Murphy, S.K.; Lemon, E.L.; Hernández-Díaz, S. Establishment of the national pregnancy registry for atypical antipsychotics. J. Clin. Psychiatry, 2015, 76(7), 986-989. doi: 10.4088/JCP.14br09418 PMID: 25939066
- Vari, I.S.; Balkau, B.; Kettaneh, A.; André, P.; Tichet, J.; Fumeron, F.; Caces, E.; Marre, M.; Grandchamp, B.; Ducimetière, P. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care, 2007, 30(7), 1795-1801. doi: 10.2337/dc06-2312 PMID: 17416791
- Musenga, A.; Saracino, M.; Sani, G.; Raggi, M. Antipsychotic and antiepileptic drugs in bipolar disorder: The importance of therapeutic drug monitoring. Curr. Med. Chem., 2009, 16(12), 1463-1481. doi: 10.2174/092986709787909604 PMID: 19355900
- Wang, Z.; Brauer, R.; Man, K.K.C.; Alfageh, B.; Mongkhon, P.; Wong, I.C.K. Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children: A systematic review and meta‐analysis. Br. J. Clin. Pharmacol., 2021, 87(11), 4101-4123. doi: 10.1111/bcp.14839 PMID: 33772841
- Hillemacher, T.; Simen, S.; Rehme, M.K.; Frieling, H. Antipsychotics during pregnancy: A systematic review. Nervenarzt, 2021, 92(5), 494-500. doi: 10.1007/s00115-020-01006-8
- Gentile, S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr. Bull., 2010, 36(3), 518-544. doi: 10.1093/schbul/sbn107 PMID: 18787227
- Gentile, S.; Fusco, M.L. Schizophrenia and motherhood. Psychiatry Clin. Neurosci., 2019, 73(7), 376-385. doi: 10.1111/pcn.12856 PMID: 31026107
- Oyebode, F.; Rastogi, A.; Berrisford, G.; Coccia, F. Psychotropics in pregnancy: Safety and other considerations. Pharmacol. Ther., 2012, 135(1), 71-77. doi: 10.1016/j.pharmthera.2012.03.008 PMID: 22483705
- Coughlin, C.G.; Blackwell, K.A.; Bartley, C.; Hay, M.; Yonkers, K.A.; Bloch, M.H. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet. Gynecol., 2015, 125(5), 1224-1235. doi: 10.1097/AOG.0000000000000759 PMID: 25932852
- Centorrino, F.; Fogarty, K.V.; Sani, G.; Salvatore, P.; Cincotta, S.L.; Hennen, J.; Guzzetta, F.; Talamo, A.; Saadeh, M.G.; Baldessarini, R.J. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum. Psychopharmacol., 2005, 20(7), 485-492. doi: 10.1002/hup.719 PMID: 16116665
- Centorrino, F.; Fogarty, K.V.; Sani, G.; Salvatore, P.; Cimbolli, P.; Baldessarini, R.J. Antipsychotic drug use: McLean Hospital, 2002. Hum. Psychopharmacol., 2005, 20(5), 355-358. doi: 10.1002/hup.700 PMID: 15957153
Supplementary files
